5'H,7'H-Spiro[cyclopropane-1,6'-pyrazolo[5,1-b][1,3]oxazine]-2'-carboxylic acid

Catalog No.: 
ACOVCL623
CAS No.: 
1428234-37-0
Molecular Formula: 
C9H10N2O3
Molecular Weight: 
194.19
5'H,7'H-Spiro[cyclopropane-1,6'-pyrazolo[5,1-b][1,3]oxazine]-2'-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$342.00InquiryInquiry
100mg98%$503.00InquiryInquiry
250mg98%$713.00InquiryInquiry
1g98%$2720.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5'H,7'H-Spiro[cyclopropane-1,6'-pyrazolo[5,1-b][1,3]oxazine]-2'-carboxylic acid
IUPAC Name5'H,7'H-spiro[cyclopropane-1,6'-pyrazolo[5,1-b][1,3]oxazine]-2'-carboxylic acid
MDL No.MFCD24387739
Molecular FormulaC9H10N2O3
Molecular Weight194.19
SMILESO=C(C1=NN(C2)C(OCC32CC3)=C1)O
InChI KeyGVYLIIJZYZSGSP-UHFFFAOYSA-N
Synonym1',3'-Dihydrospirocyclopropane-1,2'-pyrazolo[3,2-b][1,3]oxazine-6'-carboxyli;spiro[cyclopropane-1,6-pyrazolo[5,1-b][1,3]oxazine]-2-carboxylic acid;Spiro[cyclopropane-1,6'(7'H)-[5H]pyrazolo[5,1-b][1,3]oxazine]-2'-carboxylic acid;5'H,7'H-spiro[cyclopropane-1,6'-pyrazolo[5,1-b][1,3]oxazine]-2'-carboxylic acid
CAS No.1428234-37-0

Synthetic Route by SureRoute

1. ACOVCL623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOVCL623 route product structure diagram
    ACOVCL6231428234-37-0
Inquiry

2. ACOVCL623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOVCL623 route product structure diagram
    ACOVCL6231428234-37-0
Inquiry

3. ACOVCL623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOVCL623 route product structure diagram
    ACOVCL6231428234-37-0
Inquiry

Comments (0)